COVINA, Calif. -- Healtheuniverse Inc., a biotechnology development firm engaged in research, development and commercialization of regenerative medicine therapies utilizing non-embryonic adult stem cells, announces an expansion of cosmetic surgery clinics to central California by the California Institute of Cosmetic and Reconstructive Surgery (CICRS).
Healtheuniverse and CICRS) are strengthening clinical trial capabilities in a joint effort to commercialize the first non-embryonic stem cell therapy in the field of plastic, reconstructive, and cosmetic surgery.
"Our joint commercialization plans with CICRS will utilize engineered fat tissue from adult stem cells which is the ideal solution for patients with wrinkles, contour irregularities, and for breast augmentation," stated Vipul Dev, MD, chief executive officer of Healtheuniverse, Inc. "By utilizing adult stem cells via Healtheuniverse's proprietary process we hope to effectively engineer fat tissue and provide worldwide access to the technology for a variety of commercial plastic and cosmetic surgery applications."
Services at the California Institute of Cosmetic & Reconstructive Surgery range from the latest techniques in cosmetic surgery to extensive new developments in the field of reconstructive surgery. The Institute performs surgeries such as breast augmentation, facelifts, liposuction, and rhinoplasty, as well as extensive reconstructive surgery for breast cancer, burn victims, trauma victims, chronic wounds, skin cancer, and hand surgery.